Preliminary trial results demonstrated that Imfinzi plus chemo improved event-free survival in resectable early-stage gastric ...
MATTERHORN is the first global phase 3 trial to show improved event-free survival with an immunotherapy combo vs standard ...
Jornet holds the fastest known time speed record for the ascent and descent of major mountains including Mont Blanc and ...
ExplorersWeb on MSN1d
One of the Last Wild Faces in the Alps Finally ClimbedPunta Pioda doesn't have the same notoriety as the north faces of the Eiger, the Matterhorn, or the Grandes Jorasses. But ...
GlobalData on MSN4d
AstraZeneca reports positive outcomes from trial of ImfinziAstraZeneca has reported positive “high-level” outcomes from the randomised Phase III MATTERHORN trial of Imfinzi (durvalumab ...
Edinburgh News on MSN1d
Edinburgh residents are seeking relaxation in their travel in 2025, new study revealsA fifth (20%) of those from Edinburgh say they’re seeking a place to provide relaxation from their 2025 travel.
Imfinzi is one of AstraZeneca’s key growth drivers for 2025, with potential approvals in stomach and bladder cancers. The ...
Belfast News Letter on MSN1d
A quarter of people from Belfast are seeking adventure from their 2025 travelA quarter (25%) of those from Belfast say they’re seeking a place for adventure from their 2025 travel. This is according to ...
Topline results were announced from a phase 3 trial evaluating durvalumab in combination with fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) ...
A recent study conducted by the UK motorcycle insurance referral website Confused.com has identified Furka Pass in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback